Stay updated on Sabatolimab Combo in MDS: Clinical Trial
Sign up to get notified when there's something new on the Sabatolimab Combo in MDS: Clinical Trial page.

Latest updates to the Sabatolimab Combo in MDS: Clinical Trial page
- Check2 days agoChange DetectedA sitewide notice announces NIH website changes and says the agency is transitioning terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.5%

- Check9 days agoChange DetectedThe ClinicalTrials.gov footer displays an updated site revision number, from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check16 days agoChange DetectedThe website footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check37 days agoChange DetectedA new revision entry, v3.7.0, was added to the study's history, and the previous revision v3.6.6 was removed. This indicates a newer version of the record has been published, reflecting editorial or administrative updates rather than changes to study content.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6, indicating a new release or patch. The visible page content appears unchanged.SummaryDifference0.1%

- Check80 days agoChange DetectedA new revision tag v3.6.5 appears in the study record history, replacing v3.6.4. This indicates a small update to the page's revision history.SummaryDifference0.1%

Stay in the know with updates to Sabatolimab Combo in MDS: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sabatolimab Combo in MDS: Clinical Trial page.